| Literature DB >> 36101442 |
Diego Castillo-Gutierrez1, Luisa E S Hernández-Arteaga1, Manuel J Flores-Najera2, Venancio Cuevas-Reyes3, Juan M Vázquez-García1, Catarina Loredo-Osti1, Sergio Beltrán-López4, Gilberto Ballesteros-Rodea1, Antonio Gonzalez-Bulnes5, Cesar A Meza-Herrera6, Cesar A Rosales-Nieto1.
Abstract
The last third of gestation is a period of high energy and protein demand for the dam to support fetal growth and the following onset of lactation. Methionine is an essential amino acid that contributes to protein formation, fetal development, and milk synthesis; thus, is likely to have positive effects on the weight and size of the newborn and, afterward, milk yield and milk composition, which may improve growth patterns of the progeny. To test these hypotheses, we used 60 pregnant multiparous Alpine goats with similar live weights and gestational ages (~Day 100 of pregnancy; Mean ± SD; 1410 ± 14 days old and 50.4 ± 6.6 kg) and were separated into two groups: control and supplemented with the delivery. Treatments were T-MET (n = 30; received 1% herbal methionine Optimethione® dry matter based on from Day 100 of the pregnancy to delivery) or T-CTL (n = 30; served as the control and did not receive methionine). The methionine powder provided individual supplementation and was adjusted every week as the live weight and dry matter intake changed. At birth, the weight, body mass index (BMI), birth type, and sex of the kids were determined. Subsequently, the progeny was weighed weekly up to weaning. Two weeks after parturition, the milk composition was recorded weekly, and the milk yield was recorded monthly. The maternal live weight at the start (Mean ± SEM; T-CTL: 50.5 ± 1.1 vs. T-MET: 50.3 ± 1.3 kg) and end (T-CTL: 54.2 ± 1.3 vs. T-MET: 52.8 ± 1.4 kg) of the experiment did not differ statistically among treatments (p > 0.05); however, daily live weight changes tended to differ between groups (T-CTL: 73 ± 10 vs. T-MET: 51 ± 7 g day-1; p = 0.06). The birth weight (T-CTL: 3.1 ± 0.1 vs. T-MET: 3.5 ± 0.1 kg; p < 0.001), daily live weight change (T-CTL: 121 ± 6 vs. T-MET: 141 ± 6 g day-1; p < 0.01), and weaning weight (T-CTL: 8.3 ± 0.2 vs. T-MET: 9.3 ± 0.3 kg; p < 0.01) differed between treatments. The BMI at birth (T-CTL: 0.28 ± 0.01 vs. T-MET: 0.3 ± 0.01 units kg m-2; p < 0.01) and at weaning (T-CTL: 0.85 ± 0.1 kg vs. T-MET: 1.00 ± 0.06 units kg m-2; p < 0.05) differed between treatments. Milk components (protein, fat, lactose, and solids non-fat) and milk yield were similar between treatments (p > 0.05). It is concluded that the inclusion of methionine in the maternal goat diet during the last third of gestation increases the birth and growth variables of the progeny but without significant influence on the milk yield and composition.Entities:
Keywords: herbal methionine; late gestation; milk components; progeny performance
Year: 2022 PMID: 36101442 PMCID: PMC9312974 DOI: 10.3390/biology11071065
Source DB: PubMed Journal: Biology (Basel) ISSN: 2079-7737
Figure 1Scheme describing the experimental design that considered including herbal methionine (Optimethione®) in the maternal diet on the estimated gestational date 100 up to parturition. After parturition, milk yield was measured monthly and milk components (fat, protein, lactose, solids non-fat) were determined weekly.
Ingredients and chemical composition of the experimental diet (DM basis). Experimental diet was provided during the last third of gestation.
| Experimental Diet | |||
|---|---|---|---|
| Ingredient Composition (% in Diet) | Chemical Composition | ||
| Alfalfa hay | 24.2 | Dry Matter (%) | 72.3 |
| Oats hay | 45.5 | Crude Protein (%) | 8.9 |
| Maize silage | 30.3 | Metabolizable Energy (Mcal/kg) | 2.2 |
| Calcium (%) | 0.35 | ||
| Phosphorus (%) | 0.23 | ||
Effect of supplementation of herbal methionine supplement (Optimethionine®) at 1% dry matter based (T-MET) or not (T-CTL) in multiparous Alpine goats during the last third of gestation on maternal live weight at the start and end, live weight change, total birth weight, fetal growth, and total maternal gain. Values are means ± SEM.
| Variable | Treatment | ||
|---|---|---|---|
| T-CTL | T-MET | ||
|
| 30 | 30 | |
| Enrolment weight (kg) | 50.5 ± 1.1 | 50.3 ± 1.3 | 0.897 |
| Final weight (kg) | 54.2 ± 1.3 | 52.8 ± 0.1.4 | 0.472 |
| Live weight change (g/d) | 73 ± 10 | 51 ± 7 | 0.068 |
| Total Birth Weight (kg) | 5.4 ± 0.3 | 5.1 ± 0.3 | 0.434 |
| Fetal daily gain (g/d) | 108 ± 6 | 102 ± 5 | 0.434 |
| Total Maternal Gain (g/d) | −31 ± 10 | −47 ± 8 | 0.231 |
Figure 2Mean maternal live weight (± SEM) of Alpine goats during late pregnancy and lactation that received herbal methionine supplement (Optimethionine®) at 1% (dry matter basis; grey line) or not (black line) from estimated gestational d 100 up to parturition. The interaction between treatment and sampling date was not significant (p = 0.99).
Figure 3Monthly milk yield (± SEM) in Alpine goats that received herbal methionine supplement (Optimethionine®) at 1% (dry matter basis; grey line) or not (black line) during the last third of gestation. The interaction between treatment and sampling date was not significant (p = 0.20).
Figure 4Milk fat (black line ± SEM), protein (dark grey line ± SEM), lactose (light grey line ± SEM), and solids non-fat (SNF; blue line ± SEM) from Alpine goats that received herbal methionine supplement (Optimethionine®) at 1% (dry matter basis; dashed line) or not (solid line) during the last third of gestation. The interaction between treatment and sampling date was not significant for Fat (p = 0.20), Protein (p = 0.40), Lactose (p = 0.99), and SNF (p = 0.70).
Effect of herbal methionine supplement (Optimethionine®) on progeny weight and growth variables at birth and weaning of progeny from multiparous Alpine goats that received 0% (T-CTL) or 1% (T-MET; dry matter-based) of herbal methionine supplementation during the last third of gestation. Treatment data combined kid sex and birth-type data. Birth-type data combined treatment and kid sex data. Kid sex data combined treatment and birth-type data. Values are means ± SEM.
| Variable | Treatment | Interactions | |||
|---|---|---|---|---|---|
| T-CTL | T-MET | TRT*BT | TRT*Sex | ||
|
| 43 | 48 | |||
| Birth weight (kg) | 3.1 ± 0.1 | 3.5 ± 0.1 | 0.001 | 0.199 | 0.913 |
| Daily live weight gain (g d−2) | 121 ± 6 | 142 ± 6 | 0.010 | 0.729 | 0.919 |
| Weaning weight (kg) | 8.3 ± 0.2 | 9.3 ± 0.3 | 0.004 | 0.979 | 0.593 |
| BMI at birth (units kg m−2) | 0.28 ± 0.01 | 0.30 ± 0.01 | 0.010 | 0.160 | 0.240 |
| BMI at wean (units kg m−2) | 0.85 ± 0.03 | 1.00 ± 0.06 | 0.030 | 0.862 | 0.868 |
| Sex | |||||
| Female | Male | ||||
|
| 46 | 45 | |||
| Birth weight (kg) | 3.1 ± 0.1 | 3.5 ± 0.1 | 0.004 | ||
| Daily live weight gain (g d−2) | 122 ± 6 | 144 ± 6 | 0.010 | ||
| Weaning weight (kg) | 8.5 ± 0.3 | 9.2 ± 0.3 | 0.040 | ||
| BMI at birth (units kg m−2) | 0.27 ± 0.01 | 0.31 ± 0.01 | 0.001 | ||
| BMI at wean (units kg m−2) | 0.90 ± 0.06 | 0.96 ± 0.04 | 0.420 | ||
| Birth type | |||||
| Singleton | Twins | ||||
|
| 25 | 66 | |||
| Birth weight (kg) | 3.7 ± 0.1 | 3.1 ± 0.1 | 0.001 | ||
| Daily live weight gain (g d−2) | 165 ± 9 | 120 ± 4 | 0.001 | ||
| Weaning weight (kg) | 10.3 ± 0.3 | 8.3 ± 0.2 | 0.001 | ||
| BMI at birth (units kg m−2) | 0.32 ± 0.01 | 0.28 ± 0.01 | 0.002 | ||
| BMI at wean (units kg m−2) | 1.14 ± 0.11 | 0.86 ± 0.03 | 0.001 | ||